1. Home
  2. IZEA vs TENX Comparison

IZEA vs TENX Comparison

Compare IZEA & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

SELL

Current Price

$4.79

Market Cap

69.1M

ML Signal

SELL

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$11.16

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IZEA
TENX
Founded
2006
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
56.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IZEA
TENX
Price
$4.79
$11.16
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
126.5K
157.3K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,176,492.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.12
N/A
52 Week Low
$1.68
$4.63
52 Week High
$5.86
$10.65

Technical Indicators

Market Signals
Indicator
IZEA
TENX
Relative Strength Index (RSI) 44.88 78.34
Support Level $4.72 $9.40
Resistance Level $5.08 $10.55
Average True Range (ATR) 0.17 0.61
MACD -0.03 0.13
Stochastic Oscillator 15.19 87.91

Price Performance

Historical Comparison
IZEA
TENX

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: